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Many medical errors that involve drug infusion devices are related to classic interface problems. Although manufacturers are
becoming increasingly aware of human factors design considerations, many devices that are currently on the market are still sub-
optimal for human use. This places signiﬁcant responsibility for device selection on institutional purchasing groups. Theories of
naturalistic decision-making point to many potential strengths and pitfalls of group decision-making processes that may aﬀect the
ﬁnal outcome. This paper describes a retrospective analysis of decision-making process for infusion pump selection in a large
hospital and focuses on factors related to patient safety. Through a series of detailed interviews and a study of relevant docu-
mentation we characterized the nature of the decision-making, patterns of communication, and the roles of diﬀerent participants.
Findings show that although the process involves a number of diﬀerent professional groups and committees, the information ﬂow
among them is restricted. This results in inadequate representation of critical device usability considerations in the decision-making
process. While all participants view device safety as an important consideration in the selection process, administrators (who are the
ﬁnal decision-makers) tend to equate safety with technical accuracy and reliability, paying less attention to the role of human factors
in safe device use. Findings suggest that collaborative communication technology and automated evidence-based guidelines could
provide support to institutional decision-making, ensuring that the process is eﬃcient, eﬀective, and ultimately safe for the patients.
 2003 Elsevier Inc. All rights reserved.
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A successful eﬀort to reduce the impact of medical
errors requires that we understand mechanisms by
which these errors occur. The traditional approach of
blaming a clinician at the end of the causal error
chain underestimates the dynamic complexity of the
health care environment. This approach is gradually
changing as the emerging systems approach to medical
errors views errors as the result of complex interplay
of many individual, organizational, situational, and
technological factors [1]. Since sophisticated patient
care technology is omnipresent in contemporary
health care, much of error reduction eﬀort needs to be* Corresponding author. Fax: 1-212-305-3302.
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doi:10.1016/S1532-0464(03)00055-8directed at preventing device failures and device use
errors. Decisions concerning the manufacturing, se-
lection, and use of medical devices often involve
multiple players from various levels of the health care
hierarchy (e.g., administrators, CFOs, clinicians, and
biomedical engineers). The systems approach to med-
ical errors and theories of real-world decision-making
may provide us with insights as to how supporting
medical device users, manufacturers, and purchasers
can promote patient safety. This paper is speciﬁcally
concerned with institutional decision-making for pro-
moting patient safety in medical device selection and
focuses on infusion pump selection. The purpose of
the study described in paper is to characterize the
interplay of cognitive, social, organizational, and other
factors with patient safety considerations in medical
device selection.
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User errors that involve drug infusion devices ac-
count for a signiﬁcant proportion of medical errors [2].
Injuries resulting from medical device use errors far
exceed injuries arising from device failures. For example,
Cooper and colleagues [3] found that 82% of all pre-
ventable medical errors involving anesthesia devices
were due to human error. Other studies similarly point
out user error as the most common cause of patient
harm [4]. Studies have demonstrated that many user
errors are related to classic interface problems (e.g.,
poor feedback, ambiguous display messages, etc.) [4].
Redesigning the interface using human factors guide-
lines has been shown to decrease device programming
time, minimize users mental workload, and reduce the
number of programming errors [5].
Until recently, human factors issues have received
relatively little attention in medicine. The situation is
gradually changing, as health professionals and device
manufacturers are becoming increasingly aware about
the relationship between device design and medical er-
rors [6]. Organizations, such as the FDA and the Center
for Devices and Radiological Health (CDRH) have is-
sued empirical research reports and provided guidelines
for designing safer device interfaces [7]. New design
methodologies have been developed for incorporating
theories of human computer interactions into analyses
for systems design [8]. Nevertheless, despite this growing
awareness, many devices that are currently on the
market are sub-optimal from the human factors per-
spective [9]. Some of these devices were designed before
manufacturers were aware of usability considerations.
Others are ‘‘new releases’’ that have not yet been reﬁned
through real-world settings and user feedback. This
situation places signiﬁcant responsibility for the device
interface quality on the purchasers. At the same time,
device purchasers receive little support in the form of
published purchasing guidelines or continuing educa-
tion. For example, the FDA guidelines for medical de-
vice purchasers consist of a one-page list of questions
designed to guide individuals in device selection [10]. To
the best of our knowledge, no studies have attempted to
examine the extent to which usability and human factors
considerations play a role in purchasers decisions. We
believe that such research could provide valuable insight
into device purchasers information needs, serving as a
basis for designing guidelines for selecting safer devices.
Infusion pumps are widely used devices for delivering
intravenous medication and are used primarily by nur-
ses. They are routinely used in the critical care envi-
ronment where high stress and time pressure increase the
need for built-in device safety. Given the scope of its use
in hospitals, decision-making about infusion pump se-
lection is typically done on the institutional level. The
process is distributed over time and across individualsand involves a large-scale team eﬀort that requires co-
ordination of diﬀerent kinds of expertise from various
levels of hospital hierarchy (e.g., administrative, clinical,
and technological). Literature on individual and team
naturalistic decision-making provides many insights into
how various cognitive, social, and organizational factors
(e.g., communication patterns, time pressure, expertise,
and social status of the players) interact in aﬀecting real-
world decision processes.3. Strengths and pitfalls of individual and group decision-
making
The last two decades of decision-making research
have focused on the ‘‘irrationality’’ (or bounded ratio-
nality) of human decision-making [11]. Studies repeat-
edly show that human decision-making behavior rarely
conforms to the strict logic of classical decision-making
theories (e.g., Bayesian theory). Due to cognitive and
situational constraints, humans rarely engage in proba-
bilistic computations of expected utilities of diﬀerent
options. Instead, they rely on a limited set of heuristics
principles that allow them to reduce complex compu-
tational tasks to simpliﬁed but more manageable ones.
While such techniques are generally useful in reducing
cognitive load and managing uncertainty, they also
make human decision-making vulnerable to a number of
biases. For example, once individuals arrive at an
opinion, they tend to adhere to it, and may fail to revise
it on the basis of a changing situation or new evidence
(conﬁrmation bias) [12].
While classical decision-making theories view deci-
sion-making in terms of ﬁnding the most optimal of
existing options, real-world organizational decision-
makers are usually ‘‘satisﬁcers,’’ rather than ‘‘maximiz-
ers’’ [13]. Instead of conducting exhaustive searches for
the best possible alternative, they typically select an
option that is good enough, though it may not be the
best one. Montgomery [14] suggests that when individ-
uals need to select one of several alternatives, they
promptly pick one that is promising, and attempt to
establish its dominance. To be dominant, a hypothesis
needs to be at least as attractive as the competing hy-
potheses on all relevant aspects, and more attractive
than the rest on at least one aspect. Once a promising
hypothesis is selected, individuals put a lot of eﬀort into
attempting to establish its dominance. They may do it
by reassigning the relative importance of various aspects
of the situation. Research into the role of expertise in
naturalistic decision-making suggests that the profes-
sionals involved are likely to focus on eﬃcient, timely
goal completion, rather than on the process of selecting
the best alternative [15]. While ‘‘satisﬁcing’’ and ‘‘goal
completion’’ behaviors are generally useful in minimiz-
ing cognitive load and producing eﬃcient results, they
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especially undesirable in medical care. In medicine, de-
cision-makers perception of various aspects of situa-
tions depends on their individual and collaborative
expertise [16]. A range of factors, including ﬁnancial
resources, opinion of clinicians, politics, evidence from
literature, and consumer opinion, aﬀect organizational
decisions about medical equipment purchasing [17]. In
case of drug infusion devices, purchasers understanding
of human factors design issues, as well as organizational
policies and guidelines, is likely to exert strong inﬂuence
on which aspects will be taken as the ‘‘anchor’’ for es-
tablishing dominance of various alternatives.
It is generally assumed that collaborative eﬀorts may
help decision-makers eﬀectively overcome some of the
limitations of individual decision-making. Naturalistic
decision-making literature abounds with examples of
successful group decision processes in diﬀerent domains,
including medicine [16,18], science [19], and aviation
[20]. It also provides examples of group functioning that
resulted in sub-optimal decisions [21,22]. Potential
strength of group decision-making lies in its ability to
facilitate the achievement of goals that may be beyond
the range of one single individual. Research on collab-
orative decision-making identiﬁes a number of factors
crucial for eﬀective team functioning. These include
shared goals, clear role diﬀerentiation among partici-
pants, strong leadership that helps to maintain focus
without being too restrictive, shared understanding of
the process grounded in group and individual expertise,
and eﬀective communication [19]. In the instances of
group decision processes where the participants are
geographically separated, distributed and collaborative
communication technologies can eﬀectively bridge the
geographic gaps. Patel and colleagues [19] describe how
diﬀerent modalities of technology-supported communi-
cation may support diﬀerent types of interaction. For
example, synchronous communication sessions (e.g.,
conference calls) allowed participants to ask questions
and promptly restored shared understanding in mo-
ments of ambiguity, and frequently focused on executive
activities. Asynchronous communications that did not
allow immediate clariﬁcation of meaning but gave par-
ticipants more time to formulate their contributions
were more frequently used for discussing task-related
activities. The ﬁndings of Patel and colleagues [19]
suggest that multiple communication modalities are
necessary for providing eﬀective support to complex
distributed decision-making processes.
This paper describes a retrospective analysis of an
infusion pump purchase in a large urban hospital system
and focuses on cognitive and organizational factors in
the decision-making process. Special attention is given
to purchasers awareness of the human factors safety
perspective and techniques used to evaluate device
safety. The present study is part of a multi-site researchprogram, aiming to develop and test device purchasing
guidelines for patient safety. The aim is to characterize
the eﬀectiveness of the process, to identify any potential
threats to patient safety, and to provide insights into
how technology can support institutional decision-
making for device purchasing.4. Search for appropriate methodology
In order to capture the complexity of the institutional
device selection process, we had to employ methods of
study that were sensitive to the interaction of various
cognitive, social, and organizational decision factors.
Since a laboratory simulation would necessarily restrict
the complexity of the situation, we chose to employ non-
experimental methods. Methods of studying real-world
decision-making processes can be classiﬁed into two
broad categories, ﬁeld observations and retrospective
process tracing methods [23]. Field techniques involve
observing and video and audio-recording events and
processes of interest as they are occurring; retrospective
process tracing methods include techniques for studying
past events. Two retrospective process tracing tech-
niques include participants verbal reports and study of
process documents.
Retrospective methods are used when an ongoing
analysis of the process is impossible or undesirable (e.g.,
due to ethical or ﬁnancial constraints). For example,
retrospective interviews and evidence analysis have been
employed in investigations of rarely occurring high-
consequence critical incidents [24]. The challenge of
retrospective analysis lies in its reconstructive nature.
Retrospective interviews with events participants are
particularly amenable to the faults of human memory
and ‘‘impression management’’ tendencies. Moreover,
cognitive literature has documented many cases of dis-
sociation between perception and action [16,25]. Woods
[23] suggests that the plausibility of a reconstruction is
tied to its coherence and ability to account for known
events.
Retrospective analysis is strengthened when inter-
views with the participants are combined with the
analysis of evidence created during the actual process. A
match between participants recollection and process
documentation provides evidence of the validity of
participants protocols. Partial mismatch between por-
tions of the two data sources, on the other hand, can
provide important insights about participants percep-
tion of the process and attitudes towards it.
Hospital-wide purchases of major medical devices are
rare events that occur once every several years. More-
over, as discussed above, the processes are typically
distributed over long stretches of time and over many
geographical locations. Given these constraints, a ret-
rospective analysis became our choice methodology for
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involved: (a) semi-structured interviews with partici-
pants in the latest infusion pumps purchase in a major
urban hospital system and (b) analysis of documents
relevant to the purchase. The interview data were used
to construct participants representation of the process
and information ﬂow. Document analysis was used to
reconstruct the actual sequence of process-related
events.5. Methodological design
5.1. Overview of the setting
The study setting was a comprehensive urban hospi-
tal composed of two medical centers, which had merged
a few years prior to the beginning of the selection pro-
cess. The merger resulted in consolidation of all major
administrative departments under supervision of bi-
campus General Services. Prior to the merger, the two
centers had pumps manufactured by two diﬀerent ven-
dors. One of the goals of this selection process was to
standardize infusion devices across the centers by pur-
chasing a common model.
5.2. Instrumentation
As discussed above, one method of data collection for
the study involved semi-structured interviews. Design of
the interview instrument was based on Miles and Hu-
bermans guidelines for qualitative analysis [26]. Prior to
designing the questions, the investigators outlined con-
ceptual framework for data collection. According to
Miles and Huberman [26], a conceptual framework is a
graphic or narrative representation of main constructs
and variables to be studied, and hypothesized relation-Fig. 1. Conceptual framework for the study. The boxes represent aspects of
represent the directionality of causal relationships among the diﬀerent factoships among them. The basis for the design of the con-
ceptual framework can be both theoretical (based on the
theories and hypotheses guiding the study) and empiri-
cal (based on initial observations in the setting). The
beneﬁts of outlining the conceptual framework prior to
the study are twofold. First, it helps researchers to
contain the area of the study and focus their questions
on the factors and relationships within that area. Sec-
ond, it explicates researchers assumptions that will be
tested and possibly altered in the course of the study.
The initial conceptual framework for the present
study is depicted in Fig. 1. In the ﬁgure, arrows repre-
sent direction of the inﬂuence among the factors. The
ﬁgure outlines potential (hypothesized) relationships
among various factors that may aﬀect the process of
institutional medical device selection and the purchasers
perception of the process. As suggested by Miles and
Huberman [26], the design of the framework involved
both theoretical and empirical processes. Following a
systems approach to medical errors, we chose to focus
on the institutional structure, communication patterns,
and ﬁnancial factors as contributors to the process. The
studys focus on patient safety and research on medical
decision-making lead us to include purchasers knowl-
edge and attitudes towards patient safety, as well as their
perception of the process and the outcome [27,28]. The
directionality of the hypothesized relationships in the
framework was ﬁnalized after an informal discussion
with a clinician who was familiar with typical device
acquisition procedures in the hospital.
Based on the conceptual framework, interview ques-
tions covered the following aspects of the process: trig-
gers (what triggered the process), process, safety
evaluation, and decision and process quality. An interview
instrument containing key questions for each of these
aspects was developed (see Appendix A). Appropriate
probes and clariﬁcations followed each key question.the decision-making process and factors that inﬂuenced it. The arrows
rs.
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Nine participants in the latest infusion pumps pur-
chase participated in semi-structured interviews during
the study. These participants included one biomedical
engineer, four administrators, one physician, and three
nurse managers. Selection of the participants was done
after an initial informal overview of the process to as-
sure that they were representative of all individuals in-
volved.
According to the overview, the core project man-
agement group included ﬁve administrators and two
biomedical engineers. Of those, three administrators and
one engineer no longer worked at the hospital at the
time of the study. We were able to interview all core
group members who were still at the hospital, and one
former hospital administrator who played a prominent
role in the process. In addition, two clinical committees
participated in the process, Committee for Technology
in Clinics and ad-hoc Nurse Management Committee.
To obtain representative data sample for Committee for
Technology participation, we interviewed two members
who were present during each meeting (the Chair and an
administrator who also served as a reporter for the
Committee), and a physician. We also interviewed three
nurse managers from diﬀerent departments in the hos-
pital. Convergence of the data among professional
groups (administrative and clinical) was viewed as an
indicator of internal validity of the data and ‘‘repre-
sentativeness’’ of the sample. Eight interviews were au-
dio-recorded and transcribed for analysis. One
participant (a nurse manager) requested not to be audio-
recorded, so notes were taken during the interview.
5.4. Review of action documentation
Two sets of documents created during the decision-
making process were analyzed: (1) minutes of 19 meet-
ings of one of the major committees that participated in
the 3-year decision-making process (Committee for
Technology in Clinics) and (2) two user satisfaction
survey forms used during the ﬁeld evaluation of infusion
pumps.6. Analysis
The data analysis was based on several formal qual-
itative analytic methods. The interview data were ana-
lyzed using thematic coding [29]. Preliminary coding
categories were based on the core interview questions.
After the interview data were collected and transcribed,
three researchers reviewed the transcripts for regularities
and patterns and developed the ﬁnal coding scheme. The
ﬁnal coding scheme was determined upon discussion
among three researchers [29]. The ﬁnal codes included:Process Triggers, Core Project Management Group
Formation, Core Group Activity, Core Group Interactions
with Clinicians and Users, Core Group Interactions with
Vendors, Clinical Trials, Decision Inﬂuencing Factors,
Safety Considerations, Contract Negotiations, Final De-
cision, Decision Quality, and Process Quality. Two cod-
ers went through the data and marked each paragraph
unit with the appropriate coding category. A paragraph
unit included a main question and a response to it, and
when appropriate, a clarifying question and a response
(see Appendix B). Each unit could be assigned more
than one coding category. Finally, for each interview,
units of data were grouped according to the codes. Since
each code represented a theme that was related to the
conceptual research framework, review of these compi-
lations provided information about purchasing process
events and patterns in participants perception of them.
Appendix B presents an excerpt of a participants (in this
case, a core group administrator) coded protocol. This
particular selection was chosen for presentation because
it contained minimal amount of identifying information
and required minimal editing to preserve conﬁdentiality.
Appendix C presents an excerpt from the compilation of
that participants statements that was assigned with a
Core Group’s Interactions with Clinicians and Users code.
Thematic compilation of participants recollections of
various aspects of the process provided information
about trends and divergences in the data and served as a
basis for our reconstruction of the process.
Interview protocols were also used to construct par-
ticipants representations of the relationship among
various factors that inﬂuenced the process. Develop-
ment of such schematic representations was based on
semantic relationships analysis technique [30]. Semantic
relationships analysis is a method of representing verbal
utterances through directed graph structures that reﬂect
links among concepts under discussion. As such, se-
mantic relationship analysis often becomes method of
choice for representing causality. The method allowed
us to capture participants perception of the relationship
among various factors that inﬂuenced the process. De-
veloping a participants representation of the relation-
ship among various factors started with listing all
statements referring to these factors. In converting ver-
bal utterances into graph structures, concept nouns were
used to represent graph nodes and connectives were
used to represent relationships among them. For ex-
ample, one of the participants made the following
statement about factors that aﬀected the selection pro-
cess, ‘‘We looked at price, on the purchasing side and
the clinical folks looked at all those other things like is
the alarm loud enough? Did it make mistakes? Did it
jam?’’ In this statement, the speaker refers to two in-
ﬂuencing factors. One of them is the price and the other
is the clinicians evaluation of the device, which sub-
sumes a constellation of subordinate factors (alarm
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adjunctive ‘‘and’’ pronoun used in the statement indi-
cates equal status of the ﬁnancial and the clinical fac-
tors. The participants statement used in this example
provides a part of the basis for the semantic represen-
tation of an administrators view of relevant factors, as
depicted in Fig. 4.
The process documentation and interview data were
used to describe organizational structure and informa-
tion ﬂow. Finally, survey evaluation forms were con-
trasted with established design usability heuristics. The
14 heuristics used were developed by Zhang et al. [31] in
their evaluation of an online courseware system, on the
basis of 10 principles developed by Nielsen and Molich
[32]. These heuristics were also employed by Patel and
co-workers [33] in the evaluation of the infusion pump
that was purchased as a result of this decision-making
process.
Design heuristics are often used in device and/or in-
terface usability evaluation. This method, in which a
team of evaluators note a devices violations of a num-
ber of usability design principles, is a frequent method of
choice in usability engineering. We therefore used this as
a ‘‘gold standard’’ for evaluating the sensitivity of the
survey forms from the infusion pumps purchasing pro-
cess to design principle violations.Fig. 2. Information ﬂow during the process. The blocks in the ﬁgure
represent diﬀerent groups and committees that participated in the
process. The numbered arrows represent the direction of information
ﬂow (from the transmitter to the receiver of the primary information).
The dashed line separates participating groups with administrative and
engineering expertise from participating groups with clinical expertise.7. Characterization of the decision-making process
This section is organized in the following way. First,
we describe various groups that participated in the
process and the structure of information ﬂow among
these groups. Next, we describe the decision-making
process as: (a) represented in participants recollections
and (b) captured in the minutes of the Committee for
Technology in Clinics meetings. Following that, we
present analysis of survey questionnaires that were used
to assess user satisfaction during clinical evaluation of
the pumps. Finally, we analyze and discuss diﬀerences
between administrators and clinicians perceptions of
driving forces of the selection process.
7.1. Participating groups
Professionals with three types of expertise—adminis-
trative, engineering, and clinical—were involved in the
selection process. Three administrative/technical de-
partments played a major role in device selection: Pur-
chasing, Support Services, and Engineering. The
function of the Purchasing is to supervise and negotiate
ﬁnancial agreements. Support Services deals with the
distribution of supplies and devices within the hospital
and provides liaison between top-level administrators
and clinical personnel. Engineering is responsible for
technical maintenance of equipment. Individuals fromthese departments formed the Core Project Manage-
ment Group that led the selection process.
Two clinical groups participated in the selection
process. The Committee for Technology in Clinics is a
standing committee that includes high-ranking physi-
cians, engineers, and administrators. The committee
reviews and formally approves all technology acquisi-
tions in the hospital. The second clinical group was an
ad-hoc committee that included nurse managers from
major hospital units that used infusion devices. The in-
fusion pump is a device that is primarily used by ﬂoor
nurses. Since core project managers did not directly in-
teract with ﬂoor nurses, they relied on Nurse Managers
Committee to provide the liaison with the users.
7.2. Flow of information during the process
Fig. 2 describes information ﬂow among the players
in the decision-making process and is based on interview
data. As we describe in the next section, interview and
process documentation data produce somewhat diﬀerent
representations of the process. However, the ﬂow of
information in these two representations is comparable.
In a diagram based on process documentation, sequence
4–7 would loop twice.
Sequence 1–3 of the ﬁgure refers to the initial stages
of the process when Purchasing, Support Services, and
Engineering (1) identiﬁed the need to purchase new
pumps, (2) formed core project management group that
would coordinate the selection, (3) identiﬁed vendors
and models to consider, and (4) appointed Nurse
A. Keselman et al. / Journal of Biomedical Informatics 36 (2003) 31–44 37Managers Committee. It is noteworthy that during this
phase, which laid the foundation for the process, all
interactions occurred among the administrators.
Sequence 4–7 refers to the clinical evaluation of se-
lected infusion pumps, when core project managers
worked with nurse managers on organizing clinical
evaluation of selected models. The progress of these
preparations and subsequent evaluation was reported to
the Committee for Technology. Several characteristics
of this sequence have potential implications for the ﬁnal
decision. First of all, the role of the Nursing Committee
was mainly to provide liaison with the users, rather than
to contribute to the decision-making. Second of all, no
interactions occurred between the two clinical commit-
tees. Finally, no direct communication took place be-
tween (1) core project managers and ﬂoor nurses who
used the pumps and (2) the Committee for Technology
and ﬂoor nurses.
Sequence 8–12 refers to the ﬁnal decision-making
stages of the process. Upon completion of clinical
evaluations, core group managers met with top-level
hospital administrators to make the ﬁnal selection. The
Committee for Technology endorsed the decision. Fi-
nally, Purchasing department negotiated the details of
the deal with the vendor and signed the contract. Simi-
larly to the initial stage of the process, all interactions
during the ﬁnal crucial stage occurred within the ad-
ministrative framework.
7.3. Device selection process
Two sources of data, retrospective interviews with the
purchasers and minutes of Committee for Technology
meetings recorded during the process provided some-
what diﬀerent representations of the process.
7.3.1. Process as recalled by the participants
Initiating the process. According to all of the par-
ticipants, the process was triggered by an impending
expiration of the lease agreements on infusion pumps
at both hospitals. Lease agreements were supervised
by Purchasing, which initiated the process by con-
tacting Support Services and Engineering. Members of
these three departments formed the Core Project
Management Group. Next, the core administrators
selected clinical units at both sites that routinely used
infusion pumps and asked directors of those units to
nominate nurse managers for the ad-hoc nursing
committee. In describing this stage of the process, one
of the nurse managers expressed surprise that the
administrators felt the need to form an ad-hoc Nurse
Management Committee, when the hospital had a
standing Product Evaluation Committee comprised of
nurse managers of clinical units. Product Evaluation
Committee is somewhat analogous to Committee for
Technology in the Clinics, but deals with disposablesand small devices (e.g., lancets and syringes). Ac-
cording to the nurse manager, Product Evaluation
Committee members had extensive experience design-
ing survey instruments for evaluating devices, and
could make valuable contribution into the device se-
lection process.
Selecting devices to evaluate. As the next step, ad-
ministrators described reviewing the market and nar-
rowing the selection down to two candidates, Pump A
and Pump B. All of the administrators described the
process as ‘‘funnel-shaped,’’ starting with a large num-
ber of options, and gradually narrowing them down to
two, from which one had to be selected on the basis of
clinical evaluation. One of the Core Group members
provided the following account of the initial ‘‘narrow-
ing’’ process, ‘‘There were certain things where [vendors]
presented presentations on diﬀerent IV pumps and what
they can do. . . .Vendor A, and Vendor B, and I think
there were a couple of others. And then it was decided
which ones would be trialed.’’
Clinical trials and ﬁnal decision. Two pumps of two
vendors (Pump A and Pump B) were evaluated in clin-
ical units. The trial period in each unit took place over
the course of 2 weeks. Older models of both vendors had
previously been used in the hospital. The trials took
place in all major sites where infusion pumps were used
(e.g., ICU, Medical and Surgical Units, etc.). User sat-
isfaction with the pumps during the trials was assessed
via survey forms. The forms were distributed to ﬂoor
nurses and then collected by nurse managers. After ad-
ministrators evaluated the results of the surveys, they
selected Pump B. All participants in the study agreed
that Vendor B oﬀered the hospital a better ﬁnancial deal
than did Vendor A. While there were no discrepancies in
participants accounts of the evaluations, administrators
and clinicians expressed diﬀerent opinions about the
performance of the two pumps. Assessment of user
satisfaction with the pumps is discussed in a separate
section.
7.3.2. The process as reﬂected in the minutes of Commit-
tee for Technology meetings
Table 1 presents major selection process events as
represented in the minutes. In contrast with the picture
that emerges from the interviews, administrators pre-
sentations to the committee do not begin with a com-
prehensive overview and a comparative analysis of the
vendors. Instead, the process starts with consideration
of one option, Vendor Bs new model. The model is
chosen from a familiar vendor, and the purchasers
quickly proceed to ﬁnancial negotiations, and then
clinical evaluations.
It is only after signiﬁcant shortcomings are found in
Pump B (e.g., heavy weight, inadequate display lighting
which makes the pump diﬃcult to read) the second
candidate comes under consideration. Next, preliminary
Table 1
Major selection process events
Date Event
11/18/96 Announcement of Vendor Bs new model release
1/13/97 Price estimate negotiated with Vendor B; clinical
trials planned at campus 1
11/24/98 Pump B evaluation completed at campus 1
1/12/98 First mention of Vendor A; plans to trial both
pumps at both sites
4/27/98 Both vendors present ﬁnancial proposals
10/19/98 Trials completed on both campuses
3/22/99 Purchasing administration meets with the
leadership on both campuses
5/17/99 Pump B chosen by administration; committee
endorses decision
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candidate (Pump A) costs 8% more than Pump B. Both
pumps are clinically evaluated on both campuses. Core
group administrators conclude that both models are
clinically equal, and select the less expensive model.
The process representation that emerges from the
minutes is hypothesis driven (based on the need to
conﬁrm adequacy of the cheaper pump), rather than
evidence based. Yet, from the participants recollections,
the process begins not with the question of clinical ac-
ceptability of one particular vendor, but with an objec-
tive overview of many device manufacturers.
Participants seem to have little awareness of the hy-
pothesis-driven nature of the process, demonstrating
decoupling of perception and action.
7.4. Clinical evaluation of the pumps
In both accounts of pump selection, clinical evalua-
tion of the pumps stands out as an important decision
event. The evaluation took place at 10 clinical units on
each campus, and ran for 2 weeks at each unit. At the
conclusion of the trials, nurse managers distributed
survey evaluation forms to the users (ﬂoor nurses), and
later passed completed surveys to core groups admin-
istrators.
The survey was the primary means for the users to
communicate their opinion of the devices to the ad-
ministrators. During the interviews, none of the partic-
ipants could explain the origin of the survey
questionnaire. The administrators suggested that the
Nurse Managers Committee must have developed it,
but the nurse managers denied it. Review of documen-
tation revealed that two survey forms were used during
clinical trials, one for each pump. Each form was de-
veloped by its respective vendor. Pump A form included
12 yes/no questions with room for additional comments.
Pump B form included 33 Likert-scale questions.
None of the participants recalled that two diﬀerent
evaluation instruments were used in the process; somespeciﬁcally stated that one survey form was used to
evaluate both pumps. Furthermore, the participant who
kept the archive of the process-related documentation
and provided us with access to it was noticeably puzzled
upon having produced two instruments. From the per-
spective of the participants recollection of the events, it
is indeed surprising that the process allowed diﬀerent
evaluation tools to be used for diﬀerent devices. The
timeline of events as documented in the minutes of the
Committee for Technology, however, provided a plau-
sible explanation for this fact. Clinical evaluations of the
two pumps occurred at diﬀerent points in the process.
When Pump B was being evaluated, the decision-makers
did not anticipate the need to also evaluate Pump A, so
designing an objective independent evaluation tool was
not on the agenda. Similarly, when Pump A was being
evaluated, the decision-makers were focused on the
prompt completion of the particular evaluation. The
evaluation of Pump B was the event of a rather distant
past.
The diﬀerence between the forms would make com-
parisons of their data a challenging task. However, gi-
ven the usability focus of the study, we are more
concerned with each forms capability to capture viola-
tions of usability principles. To assess the form As value
as a usability evaluation tool, we compared it with the
well-established usability evaluation technique, heuristic
evaluation. Heuristic evaluation is a method in which a
team of evaluators notes a devices violations of a
number of design principles [34]. A correspondence be-
tween 12 Pump A survey questions and 14 heuristics are
outlined in Table 2. The 14 heuristics are based on
Nielsens list of 10 principles, extended by the authors
[31].
Of the 12 survey questions, only four evaluated the
pumps adherence to important usability principles, and
this was addressed in the most general way. For exam-
ple, one of the questions, ‘‘Where you able to program
the pump without diﬃculty?’’ was categorized under two
diﬀerent heuristics, Match Between the System and the
World and Flexibility and Eﬃciency, because it was not
speciﬁc enough to distinguish between the two. The re-
maining eight questions evaluated technical aspects of
the pump (e.g., Did the system remain free of leakage?
Did the pump maintain its operating functions while on
battery? Was the tubing easy to prime?). Although
useful for the immediate evaluation at hand, this yes/no
structure of answer options did not allow for meaningful
feedback for the purchasers and the designers.
7.5. Factors that inﬂuenced the process
During interviews, participants identiﬁed factors that
they viewed as relevant to the process. Figs. 3 and 4
provide schematic representations of a clinicians and an
administrators views of factors that inﬂuenced the in-
Table 2
Correspondence between Pump A survey questions and design heuristics
Heuristic Survey question
Visibility of system state Was the infusion ﬂow rate visible at all times?
Match between the system and the world Were you able to program the pump without diﬃculty?
Minimalist design None
Memory load minimized None
Informative feedback Did alarm sound appropriately? Where there frequent false alarms?
Flexibility and eﬃciency Were you able to program the pump without diﬃculty?
Good error messages None
Preventing errors None
Clear closure None
Undo-Reversible actions None
Users language None
Users in control None
Consistency and standards None
Adequate help and documentation Was the accompanying directions adequate?
Fig. 3. Schematic representation of a physicians view of relevant
factors. The blocks represent factors of the process, lines indicate
connections among the factors. Bold lines indicate factors that are
related to clinicians opinion about the pumps.
Fig. 4. Schematic representation of an administrators view of relevant
factors. The blocks represent factors of the process. Lines indicate
connections among the factors. Bold lines indicate factors that are
related to clinicians opinion about the pumps.
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are typical of members of their respective groups.
The clinician identiﬁed three categories of factors that
should have aﬀected the ﬁnal decision: cost, technical
safety, and users satisfaction. The relevance of ﬁnancial
factors was frequently mentioned by this clinician dur-
ing the interview (e.g., ‘‘ You know, its like test driving
a car. Once you are in your price range, then you test
drive a few cars, and see which one in your price range
you are gonna get.’’). He also explained that the cost of
the deal to the hospital was not limited to the price of
the pumps, but included the cost of disposable tubing
for the pumps. The clinician suggested that due to the
scale of the purchase, the hospital had good leverage in
ﬁnancial negotiations with the vendors, ‘‘Even if [the
vendors] decided to just give the pumps away, and col-lect two cents on every piece of IV tubing, they could
make millions.’’
The relevance of safety factors was also frequently
mentioned by the clinician. For example, he said that
although the hospital had the option to purchase the
pumps which were being leased at the time when the
process was initiated, such alternative was never even
considered. The pumps in question were from the gen-
eration of devices that did not have built-in free ﬂow
protection which would prevent malfunctioning pumps
from infusing medication at a dangerously accelerated
rate. Given the importance of addressing this issue, a
consensus about the need to replace the old pumps ex-
isted in the hospital.
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important consideration in hospital device selection, he
also suggested that the administrations conception of
safety-related factors was limited to technical aspects,
such as device accuracy and durability. According to
this physician, adverse events not caused by straight-
forward technical failures are often perceived as pump
operators failure, ‘‘The nurse set it wrong; somebody
else touched it; the electricity went oﬀ. . . If the electricity
went oﬀ and the pump stopped because of it, its still the
nurses fault, because it is her responsibility to make sure
the battery is charged and functions.’’
The clinician felt that while cost and technical safety
(which are associated with reliability and accuracy)
played a role in the process, users opinion did not re-
ceive a priority. He stated that the majority of the users
were not satisﬁed with Pump B, and there was ‘‘tacit
agreement’’ among users that Pump B should not be-
come the pump of choice. Yet that agreement did not
aﬀect the outcome, because ‘‘nurses certainly had the
smallest say when the administrators got together.’’ In
explaining what aﬀected clinicians opinion about the
pumps, he named several usability-related factors that
were absent from the survey forms and from the ad-
ministrators accounts. These factors included location
of buttons (e.g., START and OFF buttons should not
be next to each other), size of numbers on buttons, and
display lighting.
The administrator suggested that cost, technical
safety, and user satisfaction all played a role in the
process. He stated that ‘‘both pumps got pretty high-
satisfaction ratings,’’ and the decision ‘‘came down to a
ﬁnancial reason because as far as the clinical evaluation
was concerned, they were both equal.’’ In this process,
users satisfaction appears to be equated with their sur-
vey questionnaire responses. This participant could not
recall the content of user survey. Instead, he hypothe-
sized that the questions concerned technical issues such
as ﬂow accuracy and frequency of jams (see Fig. 4). This
example illustrates how, unlike clinicians, administra-
tors equate clinical acceptability of equipment with
technical accuracy and reliability, and not the human
factors perspective. This diﬀerence in perspective is not
surprising, given the diﬀerent expertise of these two
groups of participants.
The multi-disciplinary nature of the process aims to
ensure that all perspectives, important as they are, are
integrated into the decision-making process and its
outcome. The lack of integration creates a situation
where limited awareness of usability issues may prevent
administrators from seeking out devices that promote
patient safety via built-in fail-safe human factors design.
This argues for better means of coordination of various
perspectives among the participants. The perception
that the infusion pumps selection process was successful
in involving users in the process was common among theadministrators. As an illustration, an administrator
provided the following characterization of the process
quality, ‘‘I am not a clinician, but I do feel that it was an
excellent decision process. The best feature of the pro-
cess was that it involved a multi-disciplinary team. We
got the input of a lot of people. We [the core adminis-
trative group] listened to peoples concerns, allayed
peoples fears, brought them closer to the vendors to
make sure they met the needs of the in-service, so that
everybody was as comfortable as possible. And I believe
we did it very well.’’ Although the intentions of the
administrators were good, our study suggests that their
perception of the process and of the clinicians view of it
were not always accurate. On the more positive side, this
example illustrates administrators awareness of the
potentially positive role of the users contribution in
medical device selection. We hope that this study pro-
vides some insights into how the potential beneﬁt of
users engagement can be maximized.8. Conclusions
The study described in this paper employed retro-
spective interviews and process documentation analysis
in order to characterize a hospital decision-making
process for infusion pump purchasing. This method al-
lowed us to reconstruct the picture of the process as
perceived by the participants, and to note some dis-
crepancies between their recollections and the course of
events as represented in the documents. Since neither
data source could provide us with a complete catalogue
of the process-related events, it is possible that some of
the events and discrepancies remained hidden from the
study. The retrospective nature of the study both pro-
vides a unique opportunity to glean the participants
view of the process and suggests that conclusions need
to be drawn with care. We also realize that there is a
danger of the retrospective bias in doing these kinds of
studies. Overall, this work suggests that retrospective
analysis can play an important role in a research pro-
gram. Other methods should be used whenever possible
to supplement and validate it.
The resulting characterization points to both the
strengths and the possible ﬂaws of this particular selec-
tion process. One potential strength of the process lies in
the hospitals employment of several multi-disciplinary
groups that are comprised of individuals with three
types of expertise. This is an important ﬁrst step in any
institutional decision-making process. The potential
beneﬁt of the multi-disciplinary approach, however, is
not realized due to the restricted information ﬂow and
the lack of coordination of activities among participat-
ing groups. As a consequence, since the administrators
are the ﬁnal decision-makers who have to act on the
available information, the administrative framework
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cial stages.
Unfortunately, the users of the infusion pumps are
not adequately represented in this decision-making
process. Throughout the process, there were no direct
interactions between ﬂoor nurses who use the pumps
and (1) core group administrators or (2) high-status
clinical Committee for Technology. Users opinions
about the pumps were delivered to decision-makers
through the prism of two survey instruments which
lacked the capability to capture potential violations of
established human factors design principles. Restricted
ﬂow of information and the lack of coordination among
the participants are likely sources of problems in any
large group institutional process. Given the time pres-
sure and multiple demands of the participants jobs,
some lack of coordination may be unavoidable. Sys-
tematic scientiﬁc study of the process may help pur-
chasers ﬁnd ways to improve coordination whenever
possible.
This study speciﬁcally focuses on the role of patient
safety considerations in device selection. Our ﬁndings
suggest that while all participants view device safety as
an important factor in selection process, their concep-
tion of safety-relevant device aspects is somewhat nar-
row and there is no overall collective perception where
all perspectives are represented. While nurses and phy-
sicians clinical experience with medical devices makes
them appreciate the importance of the usability issues,
administrators equate equipment-related safety with
technical accuracy and reliability. The administrators
concern for accuracy and reliability is a viable and im-
portant one. However, since the administrators are the
ﬁnal decision-makers in the process, it is crucial that
their decision is inﬂuenced by the collective perception
of patient safety—which is largely reﬂected by clinicians
awareness of the human factors issues.
Two other characteristics of the process may poten-
tially limit its eﬀectiveness. One is the decoupling be-
tween the actual process and participants perceptions of
it. Such decoupling, described in decision-making liter-
ature [16], presents a potential barrier to the partici-
pants ability to evaluate the decision-making process
objectively. The other characteristic, also typical of real-
world decision-making, is participants strong invest-
ment in the initial hypothesis. The process starts with
the goal to conﬁrm clinical adequacy of a pre-selected
device. Only after signiﬁcant ﬂaws are found with the
initial choice do core decision-makers consider another
alternative. Such conﬁrmation bias may prompt hospital
teams to magnify strengths and overlook weaknesses of
sub-optimal devices.
While this study characterizes infusion pump selec-
tion in one speciﬁc hospital, the nature of distributed
decision-making suggests that the pitfalls described here
may be typical of the device selection process in otherinstitutions. Other studies of institutional decision-
making in health care suggest that the situation de-
scribed in this paper is characteristic of many hospital
settings [35]. Patel and Arocha [16] suggest that three
types of factors—cognitive, social, and environmental/
cultural—are instrumental in real-world collaborative
decision-making. Since many characteristics of the
clinical and administrative culture are similar across
health institutions, we may suspect that they aﬀect de-
vice selection processes in similar ways. The literature on
this topic suggests many ways in which information
technology can aid in increasing patient safety and re-
ducing medical errors (e.g., implementing computerized
order entry systems, using computerized alert systems,
etc.) [36]. Relevant technological support can also help
hospital teams conduct device selection processes more
eﬃciently. Our ﬁndings suggest that implementing au-
tomated guidelines for device selection could aid the
process by providing a more formal way of following the
evidence-based practice. In addition, collaborative
communication technologies could provide support to
this distributed, multi-team institutional decision-mak-
ing process by facilitating adequate communication be-
tween groups of participants. With these supports, a
much needed human factors and usability perspective is
less likely to be overlooked.Acknowledgments
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I. Trigger
1. Why did the site decide to purchase new or more de-
vices?
Probes• What started the process?II. Process
2. Please describe the purchasing process as you re-
member it.
Probes.• Who was involved in the purchasing process?
• How was the purchasing group formed?
• Did any policies or regulations constrain the
purchasing process?
42 A. Keselman et al. / Journal of Biomedical Informatics 36 (2003) 31–44• How did you decide which alternative devices to
consider?
• What factors were considered during the evalua-
tion of the devices?
• What steps were taken during the process?
• How were the factors combined to make a ﬁnal
decision?
• What role did patient safety play in the ﬁnal deci-
sion?
• Who made the ﬁnal decision?
• Can you summarize why the device was selected?
• What was the most important factor or factors
that led to the ﬁnal decision?III. Safety evaluation
3. How was device safety evaluated?
Probes.• What safety issues were considered? [device fail-
ure, user errors, interface design ﬂaws, environ-
mental factors, social factors]
• Who was involved in safety evaluation?
• What techniques were used to evaluate safety?IV. Decision and process quality
4. Are you aware of any issues that arose after the
device was purchased, particularly issues involving
patient safety or ease of use?
Probes• If issues arose, how were they handled or pre-
vented from occurring again?5. Do you feel that the best decision was made?
6. With respect to patient safety, do you feel that the
best decision was made?
7. How do you feel about the process used to select the
device?
8. How do you feel about the role you played in the
process?
Probes• Were your input and opinions considered?
9. What are the most positive features of the process?
10. How would you improve the process?Appendix B. Excerpt from a coded protocol with a core
groups administrator
Paragraph 1
Interviewer: If you were to summarize why [Pump
B] was selected at the end, what would be your
reasons?
Participant: I think the main reason was that it was
clinically acceptable. [Pump B] had a multi-channel. . .
I think [Pump A] did too, but. . . I am not sure. I
think basically what it came down to—and they were
both very close, it was a very close call—was that
[Pump B] came in a little better at the price. And that
was the ultimate, because the ﬁrst thing, they wereboth clinically acceptable for patient use, for safety.
Thats ﬁrst and foremost. Safety. Safety, use, being
able to use, would not put patients at any risk. They
were clinically acceptable. And then it came down to
the price.
Codes assigned to paragraph 1:
Decision Inﬂuencing Factors
Safety Considerations
Paragraph 2
Interviewer: Could you please describe the safety
evaluation.
Participant: I guess its implicitly in there. You know,
does it alarm properly. If the thing occludes, or when the
drug gets low, or the solution gets low, it is supposed to
start alarming at a certain point. You also have to set
the rate that a patient gets. Was it pretty consistent with
that, was it constantly giving alarms, was it constantly
occluding or something like that. You want to know if
those things were safe and acceptable.
Interviewer: So, safety evaluation is a part of clinical
trials?
Participant: Right. And also the biomedical team did
take a separate look at it.
Codes assigned to paragraph 2:
Safety Considerations
Clinical Trials
Decision Inﬂuencing Factors
Paragraph 3
Interviewer: Are you aware of any issues that arose
after [Pump B] was purchased? What is the satisfaction
with the pump?
Participant: Well, once it was chosen, we deployed
them in two separate times. We deployed one on [cam-
pus 1] in [date], and that side went well, I dont believe
there were any issues. The [campus 2] side had some
concerns. The main concern had to do with syringe
pumps on the side of the [pediatrics division]. And they
felt there was not enough pumps, and they were not
going to work right. There was a lot of skepticism on the
side of [campus 2].
Codes assigned to paragraph 3:
Decision QualityAppendix C. Participant 7 (Core group’s administrator),
statements assigned to Core Group’s Interactions with
Clinicians and Users coding category
Unit 1
Interviewer: Describe the process as much as you can.
Participant: Ok. Basically, what I remember is that
Purchasing ﬁrst started to speak with myself and my
staﬀ. At that point [an administrative division within
Support Services] reported to me, so they wanted just to
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knew we needed to get various people involved to get the
speciﬁcations down and to ﬁnd out what people were
looking for, so they could put out a bid. So, most people
who were involved were people from Biomedical Engi-
neering. . . I dont remember the names, but I can tell
you departments. Biomedical Engineering, Support
Services, Purchasing, people from [division within Sup-
port Services headed by the participant], Anesthesia,
and Nursing. The nursing people were all from diﬀerent
disciplines, they were from Pediatrics, because they have
certain needs—neonatal, adult ICU, medical–surgical
units, and then, the Anesthesia being for the OR, be-
cause they control most of the medication, and then also
someone from the recovery room. So, those were all the
people that got together to put this process to choose the
pumps.
Unit 2
Interviewer: Could you please talk about the Nurse
Managers Committee. Was that the standing Product
Evaluation Committee?
Participant: No, it was a separate committee, which
was almost a branch of that. If I remember correctly, we
just basically reported back and kept Committee for
Technology informed of what we were doing. And the
nursing. That basic subgroup was a separate committee.
At the time, I believe it was [name] who worked for me
and basically oversaw the [Materials Management sub-
division] piece to coordinate the doctors and the nurses
at both sites, and the others to coordinate the meetings
and bring the group together.
Unit 3
Interviewer: At what point in the process was that
committee formed?
Participant: I cant quite remember. I think people
came in initially with some basic trials, and then they
picked either two or three to try. I think it was at the
beginning, if I am not mistaken.
Unit 4
Interviewer: How often did the Nurse Managers
Committee meet?
Participant: Oh, it met pretty frequently at the be-
ginning. I think initially it was every other month, and
then at least every month for about 8 months to a year.
It was a long process. And also to get people coordi-
nated at the both sites. There was a bit of back and forth
about ﬁnally what to decide.
Unit 5
Interviewer: How good was the return rate on the
surveys?
Participant: I would say people were very helpful in
ﬁlling them out. The nurse managers also took a very
active role, because they had eﬀective interest in it. So to
get the surveys back was not hard.References
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